Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Editas Medicine (Nasdaq: EDIT) announced it will present an overview at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 10:50 a.m. ET. The event will be held virtually, and a live webcast will be accessible on Editas Medicine's website, with an archived replay available for 30 days post-presentation. As a leader in genome editing, Editas focuses on CRISPR technologies to develop precision genomic medicines for serious diseases globally.

News Market Reaction – EDIT

+7.33%

+7.33% Session move

In the trading session that priced this news, EDIT gained 7.33%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will present a company overview at the 39th Annual J.P. Morgan Healthcare Conference, held virtually, on Wednesday, January 13, 2021, at 10:50 a.m. ET.

A live webcast of the presentation will be available on the Investors section of the Editas Medicine website at www.editasmedicine.com. An archived replay will be available on the website for approximately 30 days following the presentation.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Investors
Editas Medicine Investor Relations
(617) 401-9052
ir@editasmed.com

Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

FAQ

When will Editas present at the J.P. Morgan Healthcare Conference?

Editas Medicine will present on January 13, 2021, at 10:50 a.m. ET.

Where can I watch the Editas Medicine presentation?

The presentation will be available via live webcast on the Investors section of Editas Medicine's website.

How long will the Editas Medicine presentation be available online?

An archived replay of the presentation will be available for approximately 30 days.

What technologies does Editas Medicine use for genome editing?

Editas Medicine utilizes CRISPR/Cas9 and CRISPR/Cas12a (Cpf1) genome editing systems.

What is the focus of Editas Medicine's research?

Editas Medicine is focused on developing genomic medicines for serious diseases.